Only in Titles

           Search results for: p130Cas-associated protein,P140,p140Cap,Rat,Rattus norvegicus,SNAP-25-interacting protein,SNIP,Snip,SRC kinase signaling inhibitor 1,Srcin1   

paperclip

#31542718   // Save this To Up

Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation.

Inhibition of IKK-β (inhibitor of nuclear factor kappa-B kinase subunit beta) has been broadly documentedas a promising approach for treatment of acute and chronic inflammatory diseases, cancer, and autoimmune diseases. Recently, we have identified a novel class of thiazolidine-2,4-diones as structurally novel modulators for IKK-β. Herein, we report a hit optimization study via analog synthesis strategy aiming to acquire more potent derivative(s), probe the structure activity relationship (SAR), and get reasonable explanations for the elicited IKK-β inhibitory activities though an in silico docking simulation study. Accordingly, a new series of eighteen thiazolidine-2,4-dione derivatives was rationally designed, synthesized, identified with different spectroscopic techniques and biologically evaluated as noteworthy IKK-β potential modulators. Successfully, new IKK-β potent modulators were obtained, including the most potent analog up-to-date 7m with IC value of 260 nM. A detailed structure activity relationship (SAR) was discussed and a mechanistic study for 7m was carried out indicating its irreversible inhibition mode with IKK-β (K value = 0.01 (min). Furthermore, the conducted in silico simulation study provided new insights for the binding modes of this novel class of modulators with IKK-β.

2849 related Products with: Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation.

4 Androstene 3,17 dione C Androsta-1,4,6-triene-3,1 19 Hydroxy 4 androstene 3 Multiple tumor and normal 1,4 Androstadiene 3,17 di ELISA kit CLGI,Collagenas Homogenizer for 24 sample Goat Anti-Human SNX19, (i Rectum adenocarcinoma tis LCK & DLG1 Protein Protei 6-Chloro-3-indolyl-beta-D BIRC2 & TRAF2 Protein Pro

Related Pathways

paperclip

#31541462   // Save this To Up

JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke.

C-Jun N-terminal kinase (JNK) is a pivotal MAPK (mitogen-activated protein kinase), which activated by ischemia brain injury and plays a fairly crucial function in cerebral ischemic injury. Emerging studies demonstrated that JNK-IN-8 (a JNK inhibitor with high specificity) regulates traumatic brain injury through controlling neuronal apoptosis and inflammation. However, the function of JNK-IN-8 in ischemic stroke and the mechanisms underlying of JNK-IN-8 about neuroprotection are not well understood. In this work, male rats were treated with JNK-IN-8 after transient middle cerebral artery occlusion, and then the modified improved neurological function score (mNSS), the foot-fault test (FFT), interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α) levels were assessed. We found that JNK-IN-8-treated rats with MCAO exerted an observable melioration in space learning as tested by the improved mNSS, and showed sensorimotor functional recovery as measured by the FFT. JNK-IN-8 also played anti-inflammatory roles as indicated through decreased activation of microglia and decreased IL-6, IL-1β, and TNF-α expression. Furthermore, JNK-IN-8 suppressed the activation of JNK and nuclear factor-κB (NF-κB) signaling as indicated by the decreased level of phosphorylated-JNK and p65. All data demonstrate that JNK-IN-8 inhibits neuroinflammation and improved neurological function by inhibiting JNK/NF-κB and is a promising agent for the prevention of ischemic brain injury.

2872 related Products with: JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke.

Aurora Kinase B Inhibitor ATM Kinase Inhibitor, KU- Aurora Kinase B Inhibitor Aurora Kinase B Inhibitor Aurora Kinase B Inhibitor Goat Anti-Human CKB Brain DPP IV Inhibitor, NVP DPP Caspase-3 Inhibitor Q-DEV Caspase 6 Inhibitor Drug Syk Inhibitor; Appearance Caspase 12 Inhibitor Z AT Rabbit Anti-G protein alp

Related Pathways

paperclip

#31541266   // Save this To Up

Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) has a poor prognosis because of limited treatment options. The combination of a poly ADP ribose polymerase (PARP) inhibitor with a DNA-damaging agent has shown promise in treating TNBC; however, not all patients respond to this combination. The Src protein kinase modulates multiple cancer cell properties and plays a key role in tumorigenic processes. However, Src inhibitors as single agents have shown limited effects in solid tumors. Here, we examined the antitumor effects of the Src inhibitor dasatinib, the PARP inhibitor veliparib, and the DNA-damaging agent carboplatin in TNBC models to try and identify the combination with the most clinical potential.

2602 related Products with: Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer.

Middle advanced stage bre Breast cancer test tissue Breast cancer test tissue Human breast invasive duc Breast cancer tissue arra Breast cancer tissue arra Breast cancer tissue arra Breast cancer tissue arra Top 4 types of cancer (co Breast cancer and normal Breast cancer tissue arra Breast cancer test tissue

Related Pathways

paperclip

#31539802   // Save this To Up

Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16.

The tumor suppressor p16 induces cell cycle arrest and senescence in response to oncogenic transformation and is therefore frequently lost in cancer. p16 is also known to accumulate under conditions of oxidative stress. Thus, we hypothesized it could potentially be regulated by reversible oxidation of cysteines (redox signaling). Here we report that oxidation of the single cysteine in p16 in human cells occurs under relatively mild oxidizing conditions and leads to disulfide-dependent dimerization. p16 is an all α-helical protein, but we find that upon cysteine-dependent dimerization, p16 undergoes a dramatic structural rearrangement and forms aggregates that have the typical features of amyloid fibrils, including binding of diagnostic dyes, presence of cross-β sheet structure, and typical dimensions found in electron microscopy. p16 amyloid formation abolishes its function as a Cyclin Dependent Kinase 4/6 inhibitor. Collectively, these observations mechanistically link the cellular redox state to the inactivation of p16 through the formation of amyloid fibrils.

2938 related Products with: Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16.

Multiple organ tumor tiss Anti-DDC(Netrin receptor Tissue array of ovarian g Multiple organ cancer tis Anti DDC(Netrin receptor Rabbit Anti-beta-Amyloid( Brain tumor and normal ti N-Acetyl-S-(carbamoylethy Spleen tumor tissue array 4-Azido-2,3,5,6-tetrafluo Amyloid Precursor Protein Mouse Anti-β-Amyloid 1-4

Related Pathways

paperclip

#31539562   // Save this To Up

Nitric oxide stimulates a PKC-Src-Akt signaling axis which increases human immunodeficiency virus type 1 replication in human T lymphocytes.

Human immunodeficiency virus (HIV) infections are typically accompanied by high levels of secreted inflammatory cytokines and generation of high levels of reactive oxygen species (ROS). To elucidate how HIV-1 alters the cellular redox environment during viral replication, we used human HIV-1 infected CD4T lymphocytes and uninfected cells as controls. ROS and nitric oxide (NO) generation, antioxidant enzyme activity, protein phosphorylation, and viral and proviral loads were measured at different times (2-36 h post-infection) in the presence and absence of the NO donor S-nitroso-N-acetylpenicillamine (SNAP). HIV-1 infection increased ROS generation and decreased intracellular NO content. Upon infection, we observed increases in copper/zinc superoxide dismutase (SOD1) and glutathione peroxidase (GPx) activities, and a marked decrease in glutathione (GSH) concentration. Exposure of HIV-1 infected CD4T lymphocytes to SNAP resulted in an increasingly oxidizing intracellular environment, associated with tyrosine nitration and SOD1 inhibition. In addition, SNAP treatment promoted phosphorylation and activation of the host's signaling proteins, PKC, Src kinase and Akt. Inhibition of PKC leads to inhibition of Src kinase strongly suggesting that PKC is the upstream element in this signaling cascade. Changes in the intracellular redox environment after SNAP treatment had an effect on HIV-1 replication as reflected by increases in proviral and viral loads. In the absence or presence of SNAP, we observed a decrease in viral load in infected CD4T lymphocytes pre-incubated with the PKC inhibitor GF109203X. In conclusion, oxidative/nitrosative stress conditions derived from exposure of HIV-1-infected CD4T lymphocytes to an exogenous NO source trigger a signaling cascade involving PKC, Src kinase and Akt. Activation of this signaling cascade appears to be critical to the establishment of HIV-1 infection.

1373 related Products with: Nitric oxide stimulates a PKC-Src-Akt signaling axis which increases human immunodeficiency virus type 1 replication in human T lymphocytes.

Interferon-a Receptor Typ Human anti-parainfluenza Recombinant Human Immunod Human interleukin 2(IL-2) fibronectin type III and Type II 5-phosphatase ant Recombinant Human Papillo Rabbit Anti-TNIP2 ABIN2 T Human Anti-Parainfluenza Recombinant Human Papillo Rabbit Anti-TNIP2 ABIN2 T Goat Anti-Human Collagen

Related Pathways

  •  
  • No related Items
paperclip

#31539380   // Save this To Up

Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.

Dysregulation of the seven-transmembrane (7TM) receptor Smoothened (SMO) and other components of the Hedgehog (Hh) signaling pathway contributes to the development of cancers including basal cell carcinoma (BCC) and medulloblastoma (MB). However, SMO-specific antagonists produced mixed results in clinical trials, marked by limited efficacy and high rate of acquired resistance in tumors. Here we discovered that Nilotinib, an approved inhibitor of several kinases, possesses an anti-Hh activity, at clinically achievable concentrations, due to direct binding to SMO and inhibition of SMO signaling. Nilotinib was more efficacious than the SMO-specific antagonist Vismodegib in inhibiting growth of two Hh-dependent MB cell lines. It also reduced tumor growth in subcutaneous MB mouse xenograft model. These results indicate that in addition to its known activity against several tyrosine-kinase-mediated proliferative pathways, Nilotinib is a direct inhibitor of the Hh pathway. The newly discovered extension of Nilotinib's target profile holds promise for the treatment of Hh-dependent cancers.

2075 related Products with: Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.

NF-kB II Phospho-Specific DiscoveryPak™ Hedgehog ERK Signaling Phospho-Spe Rat anti human Indian Hed T-Cell Receptor Signaling AKT PKB Signaling Phospho IGF-1R Signaling Phospho- ErbB Her Signaling Phosph p53 Signaling Phospho-Spe GPCR Signaling to MAPK ER Rat monoclonal anti mouse TGF-Beta Signaling Phosph

Related Pathways

  •  
  • No related Items
paperclip

#31539145   // Save this To Up

Influence of mesenchymal stem cells on respiratory distress syndrome in newborn swines via the JAK-STAT signaling pathway.

Acute respiratory distress syndrome (ARDS) threatens humans' health worldwide, causing huge labor and economic cost investment. This study aims to explore whether mesenchymal stem cells (MSCs) affect RDS in newborn swines via the Janus kinase-signal transducers and activators of transcription (JAK-STAT) signaling pathway by the establishment of the model of the disease.

1224 related Products with: Influence of mesenchymal stem cells on respiratory distress syndrome in newborn swines via the JAK-STAT signaling pathway.

Rat Mesenchymal Stem Cell Macrophage Colony Stimula Macrophage Colony Stimula PathwayReady™ JAK STAT p53 Signaling Phospho-Spe AMPK Signaling Phospho-Sp ERK Signaling Phospho-Spe 129 Mouse Embryonic Stem Rat Mesenchymal Cells Jak Stat Phospho-Specific T-Cell Receptor Signaling IGF-1R Signaling Phospho-

Related Pathways

  •  
  • No related Items
paperclip

#31537808   // Save this To Up

Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy.

Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by an expanded CAG repeat in the androgen receptor (AR) gene. Here, we perform a comprehensive analysis of signaling pathways in a mouse model of SBMA (AR-97Q mice) utilizing a phosphoprotein assay. We measure the levels of 17 phosphorylated proteins in spinal cord and skeletal muscle of AR-97Q mice at three stages. The level of phosphorylated Src (p-Src) is markedly increased in the spinal cords and skeletal muscles of AR-97Q mice prior to the onset. Intraperitoneal administration of a Src kinase inhibitor improves the behavioral and histopathological phenotypes of the transgenic mice. We identify p130Cas as an effector molecule of Src and show that the phosphorylated p130Cas is elevated in murine and cellular models of SBMA. These results suggest that Src kinase inhibition is a potential therapy for SBMA.

1198 related Products with: Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy.

EpiQuik Histone Methyltra Directed In Vivo Angiogen EpiQuik Histone Methyltra EpiQuik Histone Methyltra  EpiQuik Superoxide Dism p130Cas-associated protei EpiQuik Histone Methyltra  EpiQuik MBD2 Binding Ac Mouse Anti-Lipoprotein Li EpiQuik Histone Methyltra Goat Anti-Human TOM1L1 SR EpiQuik Histone Methyltra

Related Pathways

paperclip

#31537694   // Save this To Up

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition.

Lysine specific demethylase-1 (LSD1) has been shown to be critical in acute myeloid leukemia pathogenesis and this has led to the development of LSD1 inhibitors which are currently tested in clinical trials. Nonetheless, preclinical studies reported that acute myeloid leukemic cells frequently exhibit intrinsic resistance to LSD1 inhibition, and the molecular basis for this phenomenon is largely unknown. We explored the potential involvement of mammalian target of rapamycin (mTOR) in mediating the resistance of leukemic cells to LSD1 inhibitors. Strikingly, unlike sensitive leukemias, mTOR complex 1 (mTORC1) signaling was robustly triggered in resistant leukemias following LSD1 inhibition. Transcriptomic, chromatin immunoprecipitation and functional studies revealed that insulin receptor substrate 1/extracellular-signal regulated kinase signaling critically controls LSD1 inhibitor induced mTORC1 activation. Notably, inhibiting mTOR unlocked the resistance of acute myeloid leukemic cell lines and primary patient-derived blasts to LSD1 inhibitors both in vitro and in vivo. In conclusion, mTOR activation might act as a novel pro-survival mechanism of intrinsic as well as acquired resistance to LSD1 inhibitors, and combination regimens co-targeting LSD1/mTOR could represent a rational approach in acute myeloid leukemia therapy.

2669 related Products with: Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition.

EpiQuik Histone Methyltra  EpiQuik Superoxide Dism FDA Standard Frozen Tissu FDA Standard Frozen Tissu EpiQuik Histone Methyltra FDA Standard Frozen Tissu EpiQuik MBD2 Binding Acti EpiQuik Histone Methyltra  EpiQuik Superoxide Dism EpiQuik Histone Methyltra Mouse Anti-Lipoprotein Li Cell Meter™ Fluorimetri

Related Pathways

paperclip

#31536856   // Save this To Up

1,25(OH) D attenuates indoxyl sulfate-induced epithelial-to-mesenchymal cell transition via inactivation of PI3K/Akt/β-catenin signaling in renal tubular epithelial cells.

Indoxyl sulfate (IS), a uremic toxin, has been shown to promote the epithelial-to-mesenchymal transition (EMT) of human proximal tubular cells and to accelerate the progression of chronic kidney disease (CKD). Despite the well-known protective role of 1,25-dihydroxyvitamin D [1,25(OH) D] in EMT, the effect of 1,25(OH) D on IS-induced EMT in human proximal tubular epithelial cells and the underlying mechanism remain unclear. The aim of this study was to determine whether IS (0-1 mM) dose-dependently inhibited the protein expression of E-cadherin and increased the protein expression of alpha-smooth muscle actin, N-cadherin, and fibronectin.

2777 related Products with: 1,25(OH) D attenuates indoxyl sulfate-induced epithelial-to-mesenchymal cell transition via inactivation of PI3K/Akt/β-catenin signaling in renal tubular epithelial cells.

OxiSelect™ Cellular UV- Nile Red, A lipophilic dy Macrophage Colony Stimula MarkerGeneTM in vivo lacZ ECOS 101 Competent Cells Rat Mesenchymal Cells Mouse Anti-Human Fibrobla Octyl â D 1 thioglucopyr Macrophage Colony Stimula MarkerGeneTM Live Dead As Rat Anti-Mouse Dendritic Mouse Anti-Human Fibrobla

Related Pathways